Loading...
XNYS
IH
Market cap2mUSD
Jul 09, Last price  
1.43USD
1D
-2.26%
1Q
-15.06%
IPO
-93.64%
Name

Ihuman Inc

Chart & Performance

D1W1MN
XNYS:IH chart
P/E
1.04
P/S
0.12
EPS
9.32
Div Yield, %
5.82%
Shrs. gr., 5y
3.41%
Rev. gr., 5y
8.69%
Revenues
807m
-12.49%
131,867,000218,656,000531,915,000944,722,000985,517,0001,018,139,000922,201,000807,019,000
Net income
95m
-3.23%
-17,604,000-275,597,000-37,476,000-37,051,000109,819,000180,907,00098,589,00095,402,000
CFO
50m
-14.74%
-4,504,00042,627,000222,986,00038,214,0001,291,365,890172,122,00058,546,00049,917,898
Dividend
Apr 17, 20250.1 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Operating within the People's Republic of China, iHuman Inc. specializes in delivering educational resources aimed at fostering cognitive growth. Their offerings reach a broad audience, encompassing individual consumers, early learning institutions, and wholesale distributors. A significant portion of their portfolio consists of interactive and self-guided digital applications. These include popular titles such as iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, and iHuman Readers. Beyond digital platforms, iHuman Inc. also furnishes a diverse array of physical educational content, ranging from books and interactive tools to smart devices. These resources are specifically designed to cultivate essential childhood skills, such as verbal communication, analytical reasoning, autonomous reading, and creative expression. Established in 1996, the company maintains its headquarters in Beijing, located within the People's Republic of China.
IPO date
Oct 09, 2020
Employees
770
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT